Affinity DataKi: 4nMAssay Description:In vitro inhibition of recombinant human Steroid 5-alpha-reductase type IMore data for this Ligand-Target Pair
Affinity DataKi: 4nMAssay Description:In vitro inhibition of recombinant human Steroid 5-alpha-reductase type IMore data for this Ligand-Target Pair
Affinity DataKi: 9nMAssay Description:In vitro inhibition of recombinant human Steroid 5-alpha-reductase type IMore data for this Ligand-Target Pair
Affinity DataKi: 10nMAssay Description:In vitro inhibition of recombinant human Steroid 5-alpha-reductase type IMore data for this Ligand-Target Pair
Affinity DataKi: 15nMAssay Description:In vitro inhibition of recombinant human Steroid 5-alpha-reductase type IMore data for this Ligand-Target Pair
Affinity DataKi: 15nMAssay Description:In vitro inhibition of recombinant human Steroid 5-alpha-reductase type IMore data for this Ligand-Target Pair
Affinity DataKi: 17nMAssay Description:In vitro inhibition of recombinant human Steroid 5-alpha-reductase type IMore data for this Ligand-Target Pair
Affinity DataKi: 180nMAssay Description:In vitro inhibition of recombinant human Steroid 5-alpha-reductase type IMore data for this Ligand-Target Pair
Affinity DataKi: 455nMAssay Description:In vitro inhibition of recombinant human Steroid 5-alpha-reductase type 2More data for this Ligand-Target Pair
Affinity DataKi: >1.00E+3nMAssay Description:In vitro inhibition of recombinant human Steroid 5-alpha-reductase type 2More data for this Ligand-Target Pair
Affinity DataKi: >1.00E+3nMAssay Description:In vitro inhibition of recombinant human Steroid 5-alpha-reductase type 2More data for this Ligand-Target Pair
Affinity DataKi: 1.00E+3nMAssay Description:In vitro inhibition of recombinant human Steroid 5-alpha-reductase type 2More data for this Ligand-Target Pair
Affinity DataKi: 1.00E+3nMAssay Description:In vitro inhibition of recombinant human Steroid 5-alpha-reductase type 2More data for this Ligand-Target Pair
Affinity DataKi: 1.00E+3nMAssay Description:In vitro inhibition of recombinant human Steroid 5-alpha-reductase type 2More data for this Ligand-Target Pair
Affinity DataKi: >2.50E+3nMAssay Description:In vitro inhibition of recombinant human Steroid 5-alpha-reductase type 2More data for this Ligand-Target Pair
Affinity DataKi: >2.50E+3nMAssay Description:In vitro inhibition of recombinant human Steroid 5-alpha-reductase type 2More data for this Ligand-Target Pair
Affinity DataKi: 4.00E+3nMAssay Description:In vitro inhibition of recombinant human Steroid 5-alpha-reductase type IMore data for this Ligand-Target Pair
Affinity DataKi: 4.00E+3nMAssay Description:In vitro inhibition of recombinant human Steroid 5-alpha-reductase type IMore data for this Ligand-Target Pair
Affinity DataKi: 5.40E+3nMAssay Description:In vitro inhibition of recombinant human Steroid 5-alpha-reductase type 2More data for this Ligand-Target Pair
Affinity DataIC50: 30nMAssay Description:Antagonist activity at androgen receptor in human LNCaP cells harboring eGFP/ARRIPB incubated for 3 days by fluorescence methodMore data for this Ligand-Target Pair
Affinity DataIC50: 30nMAssay Description:Antagonist activity at androgen receptor in human LNCaP cells harboring eGFP/ARRIPB incubated for 3 days by fluorescence methodMore data for this Ligand-Target Pair
Affinity DataIC50: 40nMAssay Description:Antagonist activity at androgen receptor in human LNCaP cells harboring eGFP/ARRIPB incubated for 3 days by fluorescence methodMore data for this Ligand-Target Pair
Affinity DataIC50: 60nMAssay Description:Antagonist activity at androgen receptor in human LNCaP cells harboring eGFP/ARRIPB incubated for 3 days by fluorescence methodMore data for this Ligand-Target Pair
Affinity DataIC50: 70nMAssay Description:Antagonist activity at androgen receptor in human LNCaP cells harboring eGFP/ARRIPB incubated for 3 days by fluorescence methodMore data for this Ligand-Target Pair
Affinity DataIC50: 70nMAssay Description:Antagonist activity at androgen receptor in human LNCaP cells harboring eGFP/ARRIPB incubated for 3 days by fluorescence methodMore data for this Ligand-Target Pair
Affinity DataIC50: 75nMAssay Description:Antagonist activity at androgen receptor in human LNCaP cells harboring eGFP/ARRIPB incubated for 3 days by fluorescence methodMore data for this Ligand-Target Pair
Affinity DataIC50: 90nMAssay Description:Antagonist activity at androgen receptor in human LNCaP cells harboring eGFP/ARRIPB incubated for 3 days by fluorescence methodMore data for this Ligand-Target Pair
Affinity DataIC50: 100nMAssay Description:Antagonist activity at androgen receptor in human LNCaP cells harboring eGFP/ARRIPB incubated for 3 days by fluorescence methodMore data for this Ligand-Target Pair
Affinity DataIC50: 100nMAssay Description:Antagonist activity at androgen receptor in human LNCaP cells harboring eGFP/ARRIPB incubated for 3 days by fluorescence methodMore data for this Ligand-Target Pair
Affinity DataIC50: 100nMAssay Description:Antagonist activity at androgen receptor in human LNCaP cells harboring eGFP/ARRIPB incubated for 3 days by fluorescence methodMore data for this Ligand-Target Pair
Affinity DataIC50: 110nMAssay Description:Antagonist activity at androgen receptor in human LNCaP cells harboring eGFP/ARRIPB incubated for 3 days by fluorescence methodMore data for this Ligand-Target Pair
Affinity DataIC50: 130nMAssay Description:Antagonist activity at androgen receptor in human LNCaP cells harboring eGFP/ARRIPB incubated for 3 days by fluorescence methodMore data for this Ligand-Target Pair
Affinity DataIC50: 160nMAssay Description:Antagonist activity at androgen receptor in human LNCaP cells harboring eGFP/ARRIPB incubated for 3 days by fluorescence methodMore data for this Ligand-Target Pair
Affinity DataIC50: 160nMAssay Description:Antagonist activity at androgen receptor in human LNCaP cells harboring eGFP/ARRIPB assessed as reduction in PSA level incubated for 3 daysMore data for this Ligand-Target Pair
Affinity DataIC50: 170nMAssay Description:Antagonist activity at androgen receptor in human LNCaP cells harboring eGFP/ARRIPB incubated for 3 days by fluorescence methodMore data for this Ligand-Target Pair
Affinity DataIC50: 180nMAssay Description:Antagonist activity at androgen receptor in human LNCaP cells harboring eGFP/ARRIPB incubated for 3 days by fluorescence methodMore data for this Ligand-Target Pair
Affinity DataIC50: 180nMAssay Description:Antagonist activity at androgen receptor in human LNCaP cells harboring eGFP/ARRIPB incubated for 3 days by fluorescence methodMore data for this Ligand-Target Pair
Affinity DataIC50: 190nMAssay Description:Antagonist activity at androgen receptor in human LNCaP cells harboring eGFP/ARRIPB incubated for 3 days by fluorescence methodMore data for this Ligand-Target Pair
Affinity DataIC50: 190nMAssay Description:Antagonist activity at androgen receptor in human LNCaP cells harboring eGFP/ARRIPB incubated for 3 days by fluorescence methodMore data for this Ligand-Target Pair
Affinity DataIC50: 200nMAssay Description:Antagonist activity at androgen receptor in human LNCaP cells harboring eGFP/ARRIPB incubated for 3 days by fluorescence methodMore data for this Ligand-Target Pair
Affinity DataIC50: 230nMAssay Description:Antagonist activity at androgen receptor in human LNCaP cells harboring eGFP/ARRIPB incubated for 3 days by fluorescence methodMore data for this Ligand-Target Pair
Affinity DataIC50: 230nMAssay Description:Antagonist activity at androgen receptor in human LNCaP cells harboring eGFP/ARRIPB incubated for 3 days by fluorescence methodMore data for this Ligand-Target Pair
Affinity DataIC50: 240nMAssay Description:Inhibition of COX-2 (unknown origin) assessed as reduction in PGH2 formation using arachidonic acid as substrate preincubated for 5 mins followed by ...More data for this Ligand-Target Pair
Affinity DataIC50: 240nMAssay Description:Antagonist activity at androgen receptor in human LNCaP cells harboring eGFP/ARRIPB incubated for 3 days by fluorescence methodMore data for this Ligand-Target Pair
Affinity DataIC50: 300nMAssay Description:Antagonist activity at androgen receptor in human LNCaP cells harboring eGFP/ARRIPB incubated for 3 days by fluorescence methodMore data for this Ligand-Target Pair
Affinity DataIC50: 500nMAssay Description:Antagonist activity at androgen receptor in human LNCaP cells harboring eGFP/ARRIPB incubated for 3 days by fluorescence methodMore data for this Ligand-Target Pair
Affinity DataIC50: 550nMAssay Description:Antagonist activity at androgen receptor in human LNCaP cells harboring eGFP/ARRIPB incubated for 3 days by fluorescence methodMore data for this Ligand-Target Pair
Affinity DataIC50: 660nMAssay Description:Antagonist activity at androgen receptor in human LNCaP cells harboring eGFP/ARRIPB incubated for 3 days by fluorescence methodMore data for this Ligand-Target Pair
Affinity DataIC50: 740nMAssay Description:Antagonist activity at androgen receptor in human LNCaP cells harboring eGFP/ARRIPB incubated for 3 days by fluorescence methodMore data for this Ligand-Target Pair
Affinity DataIC50: 1.50E+3nMAssay Description:Antagonist activity at androgen receptor in human LNCaP cells harboring eGFP/ARRIPB incubated for 3 days by fluorescence methodMore data for this Ligand-Target Pair